Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nicholas Baetz"'
Autor:
Gerhard S. Mundinger, MD, David G. Armstrong, DPM, MD, PhD, David J. Smith, MD, Alexander M. Sailon, MD, Abhishek Chatterjee, MD, MBA, Greg Tamagnini, DPM, Joanna Partridge, MD, Nicholas Baetz, PhD, Pratima Labroo, PhD, Edward W. Swanson, MD, Nikolai A. Sopko, MD, PhD, Mark S. Granick, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 8, Iss 5, p e2840 (2020)
Summary:. An autologous homologous skin construct (AHSC) has been developed for the repair and replacement of skin. It is created from a small, full-thickness harvest of healthy skin, which contains endogenous regenerative populations involved in nat
Externí odkaz:
https://doaj.org/article/3b32a6c5fe564ab8b6fdcf5bbe1a755f
Autor:
Nikolai A. Sopko, Nicholas Baetz, Jennifer Irvin, Caroline Garrett, Michael Sieverts, Joshua Johnson, Pratima Labroo, Ian K. Robinson, James Miess
Publikováno v:
Skin Research and Technology. 27:501-510
Background Swine dorsum is commonly utilized as a model for studying skin wounds and assessment of dermatological and cosmetic medicaments. The human abdomen is a common location for dermatological intervention. Objective This study provides a correl
Autor:
William W. Li, Nikolai A. Sopko, Nicholas Baetz, Mark S. Granick, Stephen M. Milner, Pratima Labroo
Publikováno v:
International Wound Journal
A new cell-tissue technology uses a patient's skin to create an in vivo expanding and self-organising full-thickness skin autograft derived from potent cutaneous appendages. This autologous homologous skin construct (AHSC) is manufactured from a smal
Autor:
Lawrence Vernetti, Albert Gough, Nicholas Baetz, Sarah Blutt, James R. Broughman, Jacquelyn A. Brown, Jennifer Foulke-Abel, Nesrin Hasan, Julie In, Edward Kelly, Olga Kovbasnjuk, Jonathan Repper, Nina Senutovitch, Janet Stabb, Catherine Yeung, Nick C. Zachos, Mark Donowitz, Mary Estes, Jonathan Himmelfarb, George Truskey, John P. Wikswo, D. Lansing Taylor
Publikováno v:
Scientific Reports
Organ interactions resulting from drug, metabolite or xenobiotic transport between organs are key components of human metabolism that impact therapeutic action and toxic side effects. Preclinical animal testing often fails to predict adverse outcomes